From July 20, 2023 to September 8, 2023, the company has repurchased 5,323,451 shares, representing 21.86% for $3.73 million. With this, the company has completed the repurchase of 5,323,451 shares, representing 21.86% for $3.73 million under the buyback announced on July 20, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.18 USD | +0.48% |
|
-1.62% | -30.00% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.00% | 53.78L | |
+15.58% | 12TCr | |
+16.60% | 11TCr | |
+17.55% | 2.62TCr | |
-24.33% | 1.9TCr | |
-19.14% | 1.57TCr | |
-17.95% | 1.52TCr | |
-46.81% | 1.47TCr | |
+58.78% | 1.46TCr | |
+4.91% | 1.38TCr |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Tranche Update on Pasithea Therapeutics Corp.'s Equity Buyback Plan announced on July 20, 2023.